Sub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French Guiana

BACKGROUND: The treatment of Plasmodium vivax infections requires the use of primaquine, which can lead to severe haemolysis in glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals. However, most of the Latin American countries, which are still endemic for vivax malaria, lack information o...

Descripción completa

Detalles Bibliográficos
Autores principales: Petit, Florence, Bailly, Pascal, Chiaroni, Jacques, Mazières, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897928/
https://www.ncbi.nlm.nih.gov/pubmed/27267757
http://dx.doi.org/10.1186/s12936-016-1365-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897928/
https://www.ncbi.nlm.nih.gov/pubmed/27267757
http://dx.doi.org/10.1186/s12936-016-1365-8

Ejemplares similares